Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its NoveHow Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic AnalogsSilo Pharma Advances Psychedelic Patent PortfolioTryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of FloridaMajor Psychedelic Clinical Trial Data Is Right Around The CornerPsychedelic Drug Development Companies Are Leveraging Bolt On MedTech Acquisitions To Create A More Robust Patient Care 7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of MichiganNuminus Wellness Reaches Major Milestone With MAPS Sponsored MDMA StudyNuminus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSDPsyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical TrialTryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary FormulationsPsyched Wellness Commences Next Pre-Clinical Study on AME-1Atai Life Sciences Is Setting The Standard For Psychedelic Drug Development

Technical420 Site Search

Returned 14 result(s).

New Wave Holdings Is Laying The Ground Work For Multiple Revenue Streams Across Several High Growth Business Units

The psychedelic sector has been gaining significant traction and this is a trend that we have been closely following. Many analysts have compared the emergence of the psychedelic sector to the cannabis sector and we find this to be an interesting comparison. In 2014 and 2015, there were a limited…

New Wave Holdings Is Taking A Multifaceted Approach To Creating Value In The Psychedelic and Functional Mushroom Space

During the last year, there has been a large increase in the number of companies that are focused on the psychedelic sector and this is a trend that is expected to continue. Most of these companies have fascinating stories and we urge our readers to proceed with caution. When it…

Entheon Biomedical Is Changing The Way Psychedelics Interact With The Brain

There has been a substantial increase in activity in the psychedelic-based product market during the past month and this is a trend that we have been closely following. Investors need to be careful when approaching the psychedelic market and look for companies that possess specific traits. When analyzing these business,…

Absolem Health Is Focused On Bringing Quality Mushroom Based Consumer Packaged Goods To The Masses

During the last month, we have been working to identify potential leaders in the functional and medical mushroom market. The industry is in the early stages of a major growth cycle and we have seen considerable increase in interest in the market. Today, we want to highlight Absolem Health which…

COMPASS Pathways Is The Bellwether Of The Psychedelics Sector Investors Need To Be Watching

COMPASS Pathways is one of the best known companies that is focused on the psychedelic market. The business is backed by smart money (Peter Thiel) and we are favorable on the types of investors who are involved with the company. COMPASS a mental health care company that is dedicated to…

Atai Life Sciences Is Betting BIG On The Shift In Psychedelics To Treat Mental Illness

2020 has been a tough year for global markets and this is a trend that we have been closely following. During the last year, we have seen a rapid increase in the number of companies that are in the psychedelic market and this is a vertical that we have become…

Champignon Selected as Headline Partner for PSYCH: The Psychedelics Symposium at Prohibition Partners LIVE

Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce it has been selected as the Headline Partner for…

Hollister Biosciences Enters Into Definitive Agreement to Acquire AlphaMind Brands Inc.

Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the "Company" or "Hollister") – a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that it has entered into a share exchange agreement dated April 22nd, 2020 among the Company, AlphaMind Brands Inc.…

Join Us At The FUTURE OF PSYCHEDELICS – An Interactive Virtual Conference With The Top Minds In Psychedelics

During the last year, we have seen a paradigm shift with investors who have become highly focused on the psychedelics market and this is a trend that our readers need to be aware of. So far this year, the psychedelic sector has recorded significant advancements, and this is a trend…

Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee

Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, has further bolstered its pharmaceutical, nutraceutical and CPG marketing/distribution competencies…

Older Posts »

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link